Nivalis Therapeutics and Seattle's Alpine Immune Sciences to merge

Nivalis Therapeutics and Seattle's Alpine Immune Sciences to merge

BOULDER -- Nivalis Therapeutics, Inc. (NASDAQ: NVLS) and Seattle-based Alpine Immune Sciences, Inc., a privately-held biotechnology company developing novel therapies using its next-generation... Read More

Thursday April 20, 2017 0 comments Tags: Boulder, Nivalis Therapeutics, Alpine Immune Sciences, Howard Furst, Mitchell H. Gold